A Post-Market Clinical Evaluation of the Treatment of Femur Fractures with the Femoral Nail Piriformis Fossa (PF) of the T2 Alpha Femur Antegrade GT/PF Nailing System

Go Back to All Clinical Trials

A Post-Market Clinical Evaluation of the Treatment of Femur Fractures with the Femoral Nail Piriformis Fossa (PF) of the T2 Alpha Femur Antegrade GT/PF Nailing System

Brief description of study

The purpose of this study is to show the safety and performance of the T2 Alpha Femur Antegrade Piriformis Fossa (PF) Nail. Participants who will have surgery for their femur fracture and the surgeon will be using the T2 Alpha Femur Antegrade Piriformis Fossa (PF) Nail device will be used as part of your planned standard of care.This device is not an experimental medical device and is approved by the United States Food and Drug Administration (FDA).

Clinical Study Identifier: s18-01615

ClinicalTrials.gov Identifier: NCT04015154

Principal Investigator: Nirmal C Tejwani.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies